Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 440, 603 (30 March 2006) | doi:10.1038/440603a; Published online 29 March 2006
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Head-Preclinical
- Syngene International
- Bangalore, Karnataka 560099 India
Postdoctoral Positions
- Emory University
- Atlanta, Georgia, USA
Too little, too late?
Abstract
Merger fever has finally reached Germany's drug firms. But can it cure the industry's woes? Alison Abbott reports.
Despite boasting an impressive historical heritage, Germany's once powerful pharmaceutical industry is now heavily fragmented. But the company that produced the world's first blockbuster drug is making a bid to reclaim some lost ground.
To read this story in full you will need to login or make a payment (see right).
